Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICU DVT risk assessment and prophylactic enoxaparin in children
PACTR202602877136281Phase 0Completed
- Sponsor
- Hospital
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 0, open-label trial of enoxaparin in venous thromboembolism (VTE) and deep vein thrombosis (DVT) (2 arms), sponsored by Hospital. Primary endpoint: Value of thromboprophylaxis in preventing thromboembolic manifestations. Started Jun 2023; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on PACTR202602877136281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202602877136281.